Cleveland Clinic: Mellen Center for Multiple Sclerosis

Cleveland, Ohio 44195-0001

0 studies enrolling now · 2 studies all time

What they study most

Relapsing-remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis

Studies at this site

• A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) — Running, not enrolling
• Mechanistic Studies of Phase III Trial With BAF312 in Secondary Progressive Multiple Sclerosis — Completed